adplus-dvertising
Connect with us

Investment

B.C. investing $440M in cancer care as population continues to age | CTV News – CTV News Vancouver

Published

 on


The B.C. government has announced a new 10-year plan to expand cancer care as the province’s population continues to grow and age.

“Our commitment remains to ensure everyone in B.C. gets the care and support they need when they receive that difficult diagnosis,” said Health Minister Adrian Dix at a news conference with Premier David Eby on Friday.

The province will make a $440-million investment that will go towards improving cancer care, as well as research. It’s money that cancer patient Laura Malo hopes will speed up the process in getting her an appointment with an oncologist.

“Yes you had four tumours, yes you have pre-cancer cells, but you know what, you could wait up to 11 months before we start ringing alarm bells, and I went ‘you’ve got be kidding me,’” said Malo describing her conversation with a nurse last fall.

Malo thought she was cancer free nine years ago, but last year she was diagnosed once again.

“It’s really hard. It came back, it wasn’t supposed to,” she said.

She had surgery in September to remove four tumours after being told she had hormone cancer.

Her next step is to wait for an appointment with an oncologist to be prescribed life-saving medication.

“You’re giving me a death sentence by making me wait,” she said. “I have a good support system with my husband and my family and my friends, but I get nothing, absolutely nothing, from our health system and I’m not the only one.”

 “It’s unacceptable to be in a situation in our province where someone is waiting for screening or waiting for treatment to the point where it’s compromising their cancer care,” said premier Eby during the news conference.

The new plan will roll out in three phases.

Eby said $270 million will be used to expand the hours for cancer care to allow for faster access to screening, treatment, and radiation appointments.

The funding will also be used to introduce revised pay structures for oncologists and cancer-care professionals, as well as Indigenous support positions, and additional supports for patients who need to travel from rural communities for care.

Eby said $170 million of the investment will go towards the BC Cancer Foundation to provide research grants, more clinical trials and new treatments.

“It’s investments like these that will have long-lasting impacts for British Columbians,” said Eby.

According to the province, one in two British Columbians will be faced with a cancer diagnosis in their lifetime.

Kim Chi the Chief Medical Officer for BC Cancer said the goal is that 90 per cent of people are seen by their oncologist within four weeks of their referral.

For chemotherapy, the target is that 90 per cent of patients will receive the treatment within two weeks, and radiations within four weeks.

According to radiologist Dr. Paula Gordon, the targets are bold.

“There’s not enough places that do the procedure there’s not enough individuals, there’s not enough professionals who do the procedure so the waiting lists are intolerably long right now,” said Dr. Gordon.

The wait for biopsy appointments in her office are backlogged, she added.

“We do save spots for the really urgent cases but otherwise we’re booking at the end of April and early May,” she said.

In 2021, more than 30,000 people in B.C. were newly diagnosed with cancer and more than 11,000 died from the disease.

“In the coming months, we will build off this investment with additional funding to support our goals and to deliver care,” Eby added.

The province said the 10-year plan will focus on 70 key actions, which including recruiting, training and retaining health-care workers.

Since 2017, the province said, it has invested over $1 billion to strengthen cancer care.

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Investment

Tesla shares soar more than 14% as Trump win is seen boosting Elon Musk’s electric vehicle company

Published

 on

 

NEW YORK (AP) — Shares of Tesla soared Wednesday as investors bet that the electric vehicle maker and its CEO Elon Musk will benefit from Donald Trump’s return to the White House.

Tesla stands to make significant gains under a Trump administration with the threat of diminished subsidies for alternative energy and electric vehicles doing the most harm to smaller competitors. Trump’s plans for extensive tariffs on Chinese imports make it less likely that Chinese EVs will be sold in bulk in the U.S. anytime soon.

“Tesla has the scale and scope that is unmatched,” said Wedbush analyst Dan Ives, in a note to investors. “This dynamic could give Musk and Tesla a clear competitive advantage in a non-EV subsidy environment, coupled by likely higher China tariffs that would continue to push away cheaper Chinese EV players.”

Tesla shares jumped 14.8% Wednesday while shares of rival electric vehicle makers tumbled. Nio, based in Shanghai, fell 5.3%. Shares of electric truck maker Rivian dropped 8.3% and Lucid Group fell 5.3%.

Tesla dominates sales of electric vehicles in the U.S, with 48.9% in market share through the middle of 2024, according to the U.S. Energy Information Administration.

Subsidies for clean energy are part of the Inflation Reduction Act, signed into law by President Joe Biden in 2022. It included tax credits for manufacturing, along with tax credits for consumers of electric vehicles.

Musk was one of Trump’s biggest donors, spending at least $119 million mobilizing Trump’s supporters to back the Republican nominee. He also pledged to give away $1 million a day to voters signing a petition for his political action committee.

In some ways, it has been a rocky year for Tesla, with sales and profit declining through the first half of the year. Profit did rise 17.3% in the third quarter.

The U.S. opened an investigation into the company’s “Full Self-Driving” system after reports of crashes in low-visibility conditions, including one that killed a pedestrian. The investigation covers roughly 2.4 million Teslas from the 2016 through 2024 model years.

And investors sent company shares tumbling last month after Tesla unveiled its long-awaited robotaxi at a Hollywood studio Thursday night, seeing not much progress at Tesla on autonomous vehicles while other companies have been making notable progress.

Tesla began selling the software, which is called “Full Self-Driving,” nine years ago. But there are doubts about its reliability.

The stock is now showing a 16.1% gain for the year after rising the past two days.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Investment

S&P/TSX composite up more than 100 points, U.S. stock markets mixed

Published

 on

 

TORONTO – Canada’s main stock index was up more than 100 points in late-morning trading, helped by strength in base metal and utility stocks, while U.S. stock markets were mixed.

The S&P/TSX composite index was up 103.40 points at 24,542.48.

In New York, the Dow Jones industrial average was up 192.31 points at 42,932.73. The S&P 500 index was up 7.14 points at 5,822.40, while the Nasdaq composite was down 9.03 points at 18,306.56.

The Canadian dollar traded for 72.61 cents US compared with 72.44 cents US on Tuesday.

The November crude oil contract was down 71 cents at US$69.87 per barrel and the November natural gas contract was down eight cents at US$2.42 per mmBTU.

The December gold contract was up US$7.20 at US$2,686.10 an ounce and the December copper contract was up a penny at US$4.35 a pound.

This report by The Canadian Press was first published Oct. 16, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Economy

S&P/TSX up more than 200 points, U.S. markets also higher

Published

 on

 

TORONTO – Canada’s main stock index was up more than 200 points in late-morning trading, while U.S. stock markets were also headed higher.

The S&P/TSX composite index was up 205.86 points at 24,508.12.

In New York, the Dow Jones industrial average was up 336.62 points at 42,790.74. The S&P 500 index was up 34.19 points at 5,814.24, while the Nasdaq composite was up 60.27 points at 18.342.32.

The Canadian dollar traded for 72.61 cents US compared with 72.71 cents US on Thursday.

The November crude oil contract was down 15 cents at US$75.70 per barrel and the November natural gas contract was down two cents at US$2.65 per mmBTU.

The December gold contract was down US$29.60 at US$2,668.90 an ounce and the December copper contract was up four cents at US$4.47 a pound.

This report by The Canadian Press was first published Oct. 11, 2024.

Companies in this story: (TSX:GSPTSE, TSX:CADUSD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending